|
|
|
|
| LEADER |
01283nam a2200241Ia 4500 |
| 001 |
10.1016-j.jaccas.2022.05.010 |
| 008 |
220718s2022 CNT 000 0 und d |
| 020 |
|
|
|a 26660849 (ISSN)
|
| 245 |
1 |
0 |
|a Atrial Flow Regulator for Postcapillary Pulmonary Hypertension: First-in-Human Transcatheter AFR Device Implantations in RCM
|
| 260 |
|
0 |
|b Elsevier Inc.
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jaccas.2022.05.010
|
| 520 |
3 |
|
|a Restrictive cardiomyopathy (RCM) has a poor prognosis and limited treatment options apart from heart transplantation (HTx). We report on the first-in-human interventional atrial flow regulator (AFR) implantations in 3 children with RCM, leading to marked clinical and hemodynamic improvement. We propose the AFR as bridge to HTx or destination therapy in RCM. (Level of Difficulty: Advanced.) © 2022 The Authors
|
| 650 |
0 |
4 |
|a atrial flow regulator device
|
| 650 |
0 |
4 |
|a heart failure
|
| 650 |
0 |
4 |
|a left atrial hypertension
|
| 650 |
0 |
4 |
|a pulmonary hypertension
|
| 650 |
0 |
4 |
|a pulmonary vascular disease
|
| 650 |
0 |
4 |
|a restrictive cardiomyopathy
|
| 650 |
0 |
4 |
|a transcatheter intervention
|
| 700 |
1 |
|
|a Hansmann, G.
|e author
|
| 700 |
1 |
|
|a Sabiniewicz, A.
|e author
|
| 700 |
1 |
|
|a Sabiniewicz, R.
|e author
|
| 773 |
|
|
|t JACC: Case Reports
|
